Genmab A/S (GMAB)
36.57
-0.80
(-2.14%)
USD |
NASDAQ |
Oct 13, 16:00
36.68
+0.12
(+0.31%)
After-Hours: 05:51
Genmab Market Cap : 21.83B for Oct. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 13, 2026 | 21.83B |
| October 12, 2026 | 22.31B |
| October 09, 2026 | 22.13B |
| October 08, 2026 | 21.52B |
| October 07, 2026 | 21.88B |
| October 06, 2026 | 22.57B |
| October 05, 2026 | 22.97B |
| October 02, 2026 | 20.75B |
| October 01, 2026 | 20.63B |
| September 30, 2026 | 21.30B |
| September 29, 2026 | 21.24B |
| September 28, 2026 | 21.11B |
| September 25, 2026 | 21.09B |
| September 24, 2026 | 20.79B |
| September 23, 2026 | 20.75B |
| September 22, 2026 | 21.03B |
| September 21, 2026 | 20.71B |
| September 18, 2026 | 20.74B |
| September 17, 2026 | 20.62B |
| September 16, 2026 | 20.54B |
| September 15, 2026 | 20.39B |
| September 14, 2026 | 19.49B |
| September 11, 2026 | 19.39B |
| September 10, 2026 | 19.24B |
| September 09, 2026 | 19.73B |
| Date | Value |
|---|---|
| September 08, 2026 | 20.02B |
| September 04, 2026 | 20.06B |
| September 03, 2026 | 20.54B |
| September 02, 2026 | 20.43B |
| September 01, 2026 | 19.87B |
| August 31, 2026 | 19.80B |
| August 28, 2026 | 19.84B |
| August 27, 2026 | 20.36B |
| August 26, 2026 | 20.15B |
| August 25, 2026 | 20.51B |
| August 24, 2026 | 19.71B |
| August 21, 2026 | 19.97B |
| August 20, 2026 | 19.95B |
| August 19, 2026 | 20.36B |
| August 18, 2026 | 19.68B |
| August 17, 2026 | 19.61B |
| August 14, 2026 | 19.07B |
| August 13, 2026 | 18.71B |
| August 12, 2026 | 18.76B |
| August 11, 2026 | 18.42B |
| August 10, 2026 | 18.43B |
| August 07, 2026 | 18.66B |
| August 06, 2026 | 17.81B |
| August 05, 2026 | 17.47B |
| August 04, 2026 | 17.81B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AbbVie, Inc. | 484.81B |
| Ascendis Pharma A/S | 14.66B |
| Zealand Pharma A/S | 2.434B |
| Bavarian Nordic A/S | 2.684B |
| Evaxion AS | 23.02M |
Market Cap Related Metrics
| PE Ratio | 28.96 |
| PS Ratio | 5.646 |
| Price to Book Value | 3.665 |
| Price to Free Cash Flow | 26.82 |
| Price | 36.57 |
| Earnings Yield | 3.45% |
| Operating PE Ratio | 17.50 |
| Normalized PE Ratio | 23.73 |